The relationships between blood levels of inflammatory and destructive biomarkers (TNF-α, IL-1β, IL-6, IL-8, soluble CD40 ligand, high-sensitivity C-reactive protein, endothelial adhesion molecules, matrix metalloproteinase 3 and 9 and their tissue inhibitor type 1) were studied in men with coronary atherosclerosis before and 5 years after coronary artery bypass surgery. In men with unfavorable course of coronary atherosclerosis in the delayed period, the initial blood levels of C-reactive protein and TNF-α by 1.7 and 3.0 times surpassed those in patients with favorable course of the disease. Associations were revealed between elevated blood content of high-sensitivity C-reactive protein (p=0.01, odds ratio of 1.33) and IL-8 (p=0.02, odds ratio of 1.02) and deaths in the delayed period; IL-6 (p=0.01, odds ratio of 1.02) and cases of myocardial infarction; C-reactive protein (p=0.02, odds ratio of 1.24) and unfavorable course of the delayed period in general (death, myocardial infarction, worsening of angina pectoris functional class).
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Yu. N. Belenkov, R. S. Akchurin, A. P. Savchenko, et al., Kardiologiya, 42, No. 5, 42-47 (2002).
L. A. Bokeriya, I. N. Stupakov, and I. V. Samorodskaya, Byull. Nauch. Tsentra Serdechno-Sosudistoi Khirurgii Im. Bakuleva, 2, No. 5, 16-50 (2001).
Yu. I. Ragino, A. M. Chernyavski, Ya. V. Polonskaya, et al., Bull. Exp. Biol. Med., 153, No. 2, 186-189 (2012).
Yu. I. Ragino, A. M. Chernjavski, Ya. V. Polonskaja, et al., Bull. Exp. Biol. Med., 149, No. 5, 587-590 (2010).
E. J. Armstrong, D. A. Morrow, and M. S. Sabatine, Circulation, 113, No. 6, e72-e75 (2006).
E. J. Armstrong, D. A. Morrow, and M. S. Sabatine, Circulation, 113, No. 9, e382-e385 (2006).
L. M. Biasucci, Circulation, 110, No. 25, е560-е567 (2004).
G. A. Bonaterra, S. Zugel, and R. Kinscherf, Curr. Mol. Med., 10, No. 2, 180-205 (2010).
M. Bucova, M. Bernadic, and T. Buckingham, Bratisl. Lek. Listy, 109, No. 8, 333-340 (2008).
J. P. Empana, F. Canoui-Poitrine, G. Luc, et al., Eur. Heart J., 29, No. 16, 1966-1974 (2008).
J. C. Fruchart, Pathophysiology of Stages of Development of Atherosclerosis. Handbook of Dyslipidemia and Atherosclerosis, Lille (2003), Pt. 1, pp.1-65.
Y. S. Kwok, C. Kim, and P. A. Heidenreich, Am. J. Med., 111, No. 2, 89-95 (2001).
E. Lubos, R. Schnabel, H. J. Rupprecht, et al., Eur. Heart J., 27, No. 2, 150-156 (2006).
R. Sukhija, I. Fahdi, L. Garza, et al., Am. J. Cardiol., 99, No. 7, 879-884 (2007).
N. Varo, J. A. de Lemos, P. Libby, et al., Circulation, 108, No. 9, 1049-1052 (2003).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 155, No. 3, pp. 289-292, March, 2013
Rights and permissions
About this article
Cite this article
Ragino, Y.I., Chernyavskiy, A.M., Tsimbal, S.Y. et al. Relationship of Blood Levels of Inflammatory and Destructive Biomarkers in Coronary Atherosclerosis with Long-Term Results of Surgical Revascularization. Bull Exp Biol Med 155, 314–317 (2013). https://doi.org/10.1007/s10517-013-2142-0
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-013-2142-0